Hot Pursuit     26-Dec-23
Biocon Ltd soars 1.18%, Gains for third straight session
Biocon Ltd is quoting at Rs 249.2, up 1.18% on the day as on 12:49 IST on the NSE. The stock is down 6.1% in last one year as compared to a 18.18% gain in NIFTY and a 30.28% gain in the Nifty Pharma index.

Biocon Ltd is up for a third straight session in a row. The stock is quoting at Rs 249.2, up 1.18% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.37% on the day, quoting at 21428.9. The Sensex is at 71339.72, up 0.33%. Biocon Ltd has added around 6.91% in last one month.

Meanwhile, Nifty Pharma index of which Biocon Ltd is a constituent, has added around 4.02% in last one month and is currently quoting at 16394.35, up 0.88% on the day. The volume in the stock stood at 21.74 lakh shares today, compared to the daily average of 32.46 lakh shares in last one month.

The benchmark December futures contract for the stock is quoting at Rs 249.85, up 1.17% on the day. Biocon Ltd is down 6.1% in last one year as compared to a 18.18% gain in NIFTY and a 30.28% gain in the Nifty Pharma index.

The PE of the stock is 492.4 based on TTM earnings ending September 23.

Previous News
  Biocon consolidated net profit declines 56.74% in the March 2024 quarter
 ( Results - Announcements 16-May-24   18:25 )
  Biocon PAT slides 57% to Rs 136 crore in Q4 FY24
 ( Hot Pursuit - 17-May-24   10:37 )
  Biocon gets nod from SAHPRA for Tacrolimus capsules
 ( Hot Pursuit - 20-Apr-24   15:36 )
  Biocon
 ( Results - Analysis 13-Nov-23   12:15 )
  Biocon Ltd up for third straight session
 ( Hot Pursuit - 02-Feb-24   13:05 )
  Biocon Ltd spurts 1.22%, gains for third straight session
 ( Hot Pursuit - 07-Jun-24   13:05 )
  ICICI Bank board to mull fund raising proposal
 ( Hot Pursuit - 20-Apr-24   14:40 )
  Biocon Ltd up for third consecutive session
 ( Hot Pursuit - 29-Sep-23   13:05 )
  Biocon consolidated net profit declines 29.78% in the June 2023 quarter
 ( Results - Announcements 11-Aug-23   07:47 )
  Biocon’s Andhra Pradesh facility gets 3 USFDA observations
 ( Hot Pursuit - 15-Jun-24   16:32 )
  Eris Lifesciences avails term loan of Rs 280 cr from Citi Bank
 ( Corporate News - 09-Nov-23   09:15 )
Other Stories
  RVNL gains on emerging as L-1 bidder for Rs 133-cr railway project
  03-Jul-24   15:38
  Cholamandalam Financial Holdings Ltd leads losers in 'A' group
  03-Jul-24   15:00
  Sakuma Exports Ltd leads losers in 'B' group
  03-Jul-24   14:45
  NTPC power generation climbs 9.5% YoY in Q1
  03-Jul-24   14:41
  Volumes soar at MMTC Ltd counter
  03-Jul-24   14:30
  Oil and Gas shares fall
  03-Jul-24   14:00
  Real Estate stocks edge lower
  03-Jul-24   14:00
  Energy stocks edge lower
  03-Jul-24   14:00
  Sundaram-Clayton gains after board OKs to raise funds upto Rs 400 cr
  03-Jul-24   13:38
  JSW Infra's subsidiary concession agreement V.O. Chidambaranar Port Authority
  03-Jul-24   13:34
Back Top